Shinichi Muramatsu
Directeur/Membre du Conseil chez Gene Therapy Research Institution Co., Ltd.
Profil
Shinichi Muramatsu currently works as a Director & Chief Risk Officer at Gene Therapy Research Institution Co., Ltd.
Postes actifs de Shinichi Muramatsu
| Sociétés | Poste | Début |
|---|---|---|
Gene Therapy Research Institution Co., Ltd.
 Gene Therapy Research Institution Co., Ltd. BiotechnologyHealth Technology Gene Therapy Research Institution Co., Ltd. provides gene therapies for refractory diseases. It focuses on Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and Alzheimer’s disease. The company was founded on May 16, 2014 and is headquartered in Kawasaki, Japan. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Gene Therapy Research Institution Co., Ltd.
Gene Therapy Research Institution Co., Ltd. BiotechnologyHealth Technology Gene Therapy Research Institution Co., Ltd. provides gene therapies for refractory diseases. It focuses on Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and Alzheimer’s disease. The company was founded on May 16, 2014 and is headquartered in Kawasaki, Japan. | Health Technology |
